2019 UDS Spring Conference
Please join your colleagues in Springdale on April 26-27, 2019, for an update on the latest evidence-based approaches to diagnosis of rare dermatologic diseases, use of dermascopy in the diagnosis of neoplasm, advances in aesthetic dermatology, and improved surgical outcome in linear repair and scar revision. In addition to these clinical topics, Bruce Theirs, MD, President-Elect of the American Academy of Dermatology, will discuss recent initiatives of the AAD.
Speakers for the 2019 annual meeting include the following:
- Daniel Eisen, MD – UC Davis
- Edward Cowen, MD – Head of the NIH Dermatology Consultation Service
- Jill Waibel, MD – Miami Dermatology and Laser Institute
- David Swanson, MD – Mayo Clinic Phoenix
- Bruce Thiers, MD – President-Elect, American Academy of Dermatology
There is still time to register online @ utahderm.com for what should be a fun and informative meeting in southern Utah.
After attending this conference, learners should be able to:
Utilize improved surgical technique in linear repair and scare revision;
Employ dermoscopy in general dermatology for the diagnosis of neoplasm as well as a differential diagnosis;
Diagnose rare and newly described dermatologic diseases;
Describe new therapies for skin diseases using articles published in the Journal of the American Academy of Dermatology and assess the efficacy of these therapies vs. existing agents;
Incorporate the latest advances in aesthetic dermatology in clinical practice.
CONTINUING MEDICAL EDUCATION
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Utah Medical Association through the joint providership of the UMA Foundation and the Utah Dermatology Society. The UMA Foundation is accredited by the Utah Medical Association to provide continuing medical education for physicians.
The UMA Foundation designates this live activity for a maximum of 7.0 AMA PRA Category 1 credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The UMA Foundation and the UDS adhere to ACCME standards regarding the independence of continuing medical education from commercial influence. The UDS has obtained disclosures from all those with control over content. No one involved in the planning or presentation of this meeting has disclosed any relevant financial relationships with a commercial interest.
Jill Waibel, MD, has disclosed that she has the following financial relationships with commercial entities:
- Clinical trials – Cytrellis Biosystems, Medisca Pharmaceuticals, Hygia Life Sciences, Sciton, Sebacia, Candela, Michaelson Diagnostics, Dominion Aesthetics, DermaSensor, Recros Medica, Eli Lilly, Miramar Labs, Novartis
- Advisory Board member – Sciton, Sebacia, Candela, Dominion Aesthetics
- Speaker – Novartis, Candela
- Consultant – Candela
- Clinical Work – Strata Skin Sciences
- Medical Equipment – Sciton, Candela, Michaelson Diagnostics
All others involved in planning or presenting at this conference have no financial relationships to disclose.